Counter temporarily out of order due to NetScrape Server stupidity.
This is a partial list of recreational and medical drugs which inhibit
the P450 enzymes 2D6, 3A4, and 3A5. Not all of them will inhibit all of
the P450 enzymes, but it's safe to say that a substantial number of these
will interact with DXM.
Generally speaking, inhibitors of P450-2D6 include antidepressants
(both SSRIs and tricyclics, and possibly MAO inhibitors), antiparasitics
(especially antimalarials), antihistamines (both prescription and
over-the-counter), neuroleptics, beta blockers (drugs for high blood
pressure), and antineoplastics (anti-cancer drugs). Methadone
is a P450-2D6 inhibitor, and it is likely that many alkaloids,
especially of plant origin, may be mild to moderate P450-2D6 inhibitors.
P450 Inhibitors
| Drug | Uses | P450-2D Enzymes | Potency | Ref
|
|---|
| ajmalicine | | 2D6 | strongest
| 167
|
| carbon monoxide | poison | 2D6 |
| 163
|
| chloroquine | antiparasitic | 2D6 | med-low
| 175
|
| chlorpheniramine | antihistamine | 2D | med-high
| 154
|
| citalopram | antidepressant | 2D6 | med-low
| 169
|
| clozapine | antipsychotic | 2D6 | low
| 174
|
| desipramine | antidepressant | 2D6 | low
| 155
|
| diphenhydramine | antihistamine | 2D | med-high
| 154
|
| doxorubicin | anticancer | 2D6 | med-low
| 168
|
| fluoxetine | antidepressant | 2D6 | med-high
| 155
|
| fluvoxamine | antidepressant | 2D6 | med-high
| 155
|
| imipramine | antidepressant | 2D6 | med
| 155
|
| lomustine | anticancer | 2D6 | med
| 168
|
| mepyramine | antihistamine | 2D6 | high
| 154
|
| methadone | addiction treatment | 2D6 | med
| 165
|
| moclobemide | MAO-A Inh. (reversible)
| 2D6, also 2C19, 1A2 |
| 150
|
| nortryptiline | antidepressant | 2D6 | med-low
| 158
|
| oxamniquine | antiparasitic | 2D6 | med-low
| 175
|
| paroxetine | antidepressant | 2D6 | high
| 155
|
| PCP | recreational | 2D |
| 153
|
| primaquine | antiparasitic | 2D6 | med-low
| 175
|
| propranolol | beta-blocker | 2D6 | low
| 159
|
| quinidine | | 2D6 |
| 151
|
| quinine | antiparasitic | 2D |
| 154
|
| sertraline | antidepressant | 2D6 | med-high
| 170
|
| triprolidine | antihistamine | 2D | med-high
| 154
|
| vinblastine | anticancer | 2D6 | med-low
| 168
|
| vinorelbine | anticancer | 2D6 | med-low
| 168
|
| Drug | Uses | P450-3A Enzymes | Potency | Ref
|
|---|
| 7,8-benzoflavone | | 3A4 (activator) |
| 156
|
| cannabidiol | component of marijuana | 3A | med
| 164
|
| cocaine | recreational | 3A | low
| 160
|
| clotrimazole | agricultural fungicide
| 3A (activator) | very high
| 157
|
| cyclophosphamide | | 3A | low?
| 161
|
| ifosfamide | | 3A | low?
| 161
|
| ketoconazole | | 3A |
| 148
|
| pilocarpine | cholinomimetic | 3A | low
| 152
|
| Drug | Uses | P450-3A Enzymes | Potency | Ref
|
|---|
| 1-aminobenzotriazole | | Nonspecific | med-high
| 162
|
| chlorophyllin | geriatric | Nonspecific |
| 149
|
| general anaesthetics | | Nonspecific |
| 166
|
One reference (167)
gives the general characteristics of P450-2D6
inhibitors as
a positive charge on a nitrogen atom, and a flat
hydrophobic region, the plane of which
is almost perpendicular to the N-H axis and maximally extends up
to a distance of 7.5 A from the nitrogen atom. Compounds with high
inhibitory potency had additional functional groups with
negative molecular electrostatic potential and hydrogen bond acceptor
properties on the opposite side at respective distances of 4.8-5.5A and
6.6-7.5A from the nitrogen atom.
A computer model of the P450-2D6 cytochrome has been
constructed (173).
- alcohol
- Targets and blocks GABA and NMDA channels, as well as probably
having an effect on other ion channels (voltage-dependent and receptors).
Actually, alcohol is not well understood in comparison to other drugs.
- amphetamine
- Causes a non-vesicular release of dopamine and noradrenaline by
neurons which normally secrete them. May have some direct effect on
dopamine and noradrenaline receptors, but this is insignificant compared to
its neurotransmitter releasing effect.
- barbiturates
- Targets and binds to a specific site on GABA receptors, which
activates them. This site is called the barbiturate binding site
(appropriately enough). This is a different site from alcohol and
benzodiazepines, so that if you combine any of these three, they will not
compete for the same binding sites. Consequently, there is a
synergistic effect, which can be quite dangerous.
- benzodiazepines
- Similar to barbiturates, except for two factors. First, the
binding site is the benzodiazepine site on the GABA receptor. Second, when
a benzodiazepine binds to this site, the GABA receptor is not immediately
activated; instead, the natural action of GABA is enhanced. This is the main
reason benzodiazepines are safer than barbiturates, and have different
effects.
- "blues"
- An antihistamine (targeting and activating the H1 receptor)
which probably has sigma1 antagonist properties; when used in
combination
with pentazocine, it probably blocks the sigma activity of the latter. Rarely
found. The only reason I'm mentioning it is because I heard about it in a
comedy skit called "Rock and Roll Doctor" and always wondered what "blues"
were (until I found out). Well, if you wondered too, now you know.
- caffeine
- Targets and blocks an adenosine receptor, probably A2
but possibly A1.
This is an inhibitory presynaptic receptor, i.e., when activated it decreases
the amount of neurotransmitter released by a neuron. Thus, caffeine blocks
some of this inhibition, increasing neural activity.
- cannabis
- Targets a specific receptor (or family of receptors) designated
anandamide. It is not yet known whether cannabis (actually, THC) is an
agonist or antagonist at this receptor.
- codeine
- See morphine.
- coffee
- See caffeine.
- cocaine
- A dopamine reuptake inhibitor; cocaine blocks the transporter which
takes used dopamine out of the way. Thus, dopamine secreted by a neuron
keeps activating receptors over and over. Cocaine is also a sigma1
agonist, and has blocking abilities on certain ion channels (by which it exerts
its local anesthetic effects).
- Demerol
- See morphine.
- glue
- See solvents.
- heroin
- See morphine.
- LSD
- Targets 5HT2A and 5HT2C, where it acts either
as an antagonist or a partial
agonist. Also has some dopaminergic activity; however, the majority of its
effects are mediated through the 5HT receptors.
- marijuana
- See cannabis.
- MDA
- See MDMA. Release binding spectrum is probably different, and MDA
may have additional effects on receptors.
- MDMA
- Similar to amphetamine, except that MDMA causes a nonvesicular
release of dopamine and serotonin (5HT). Probably has other effects as well,
some of which may be significant.
- methamphetamine
- Similar to amphetamine, possibly with more dopamine release.
- morphine
- Targets opioid receptors mu, kappa, and delta, where it
acts as an agonist. Slight differences in binding spectrum to opiate receptors
exist among the various natural and synthetic opiates.
- nitrous oxide
- Seems to affect phospholipid membranes, although some effects
may be mediated by NMDA and GABA channels, and other ion channels.
General anesthetics are similar to nitrous oxide, although more toxic.
- opium
- See morphine.
- Ritalin
- Similar to cocaine, but less potent.
- seconal
- See barbiturates.
- solvents
- Same general theory as alcohol and nitrous oxide, but considerably
more toxic to neurons (and the liver).
- Valium[tm]
- See benzodiazepines.
- yohimbine
- Targets and blocks alpha2 adrenergic receptors. These are
autoreceptors, which normally limit the activity of adrenergic neurons. By
blocking alpha2 receptors, yohimbine increases the activity of
these neurons.
Here are a few sigma ligands you may wish to research (if you are
interested in that sort of thing):
Sigma1 ligands in rough order of potency:
- (+)-pentazocine
- haloperidol
- DTG
- (+)-3-PPP
- DXM
- (+)-SKF 10,047
- (+)-cyclazocine
- (-)-pentazocine
- PCP
- (-)-SKF 10,047
Sigma2 ligands in rough order of potency:
- DTG
- haloperidol
- (+)-3-PPP
- (-)-pentazocine
- PCP
- (+)-pentazocine
- (-)-SKF 10,047
P>
A known sigma antagonist is N-[-2-(3,4-dichlorophenyl)ethyl]- N-methyl-2-[1-
pyrimidinyl-1-piperazine] butanol; a sigma1 selective
antagonist is (1-(cyclopropylmethyl)- 4-2'4"-fluorophenyl)-
(2'-oxoethyl)piperidine HBr.